These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23715514)

  • 1. Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.
    Wang XY; Yu H; Linnoila RI; Li L; Li D; Mo B; Okano H; Penalva LO; Glazer RI
    Oncotarget; 2013 May; 4(5):739-50. PubMed ID: 23715514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
    Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI
    Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
    Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
    Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.
    Wang XY; Yin Y; Yuan H; Sakamaki T; Okano H; Glazer RI
    Mol Cell Biol; 2008 Jun; 28(11):3589-99. PubMed ID: 18362162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
    Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
    PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
    Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
    Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
    Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
    Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
    Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
    RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients.
    Moghbeli M; Forghanifard MM; Aarabi A; Mansourian A; Abbaszadegan MR
    Pathol Oncol Res; 2014 Apr; 20(2):427-33. PubMed ID: 24163304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
    Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
    BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
    BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R; Korourian A; Shariftabrizi A; Madjd Z
    Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
    Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.